1-1 of 1
Marco Peronaci, MSc
Close
Sort by
Journal Articles

Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma

Sara Redaelli, PhD, Monica Ceccon, PhD, Alessandra Pirola, MSc, Marco Peronaci, MSc, Carlo Gambacorti-Passerini, MD, Luca Mologni, PhD
Journal: Blood
Blood (2015) 126 (23): 3710.
https://doi.org/10.1182/blood.V126.23.3710.3710
Published: 2015